Mozobil

Medicinal product

(Invented) name

Mozobil

Active substance (s)

Pleriksaforas

Strength

20 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L03AX16, Plerixafor

Marketing authorisation holder

Sanofi B.V., Nyderlandai

Date of authorisation

2009-07-31

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Subcutaneous use	1 ml
Pleriksaforas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
37096	50715	1050715	flakonas	1,2 ml N1		Receptinis	EU/1/09/537/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2009-07-31	Registruotas